The evolving landscape of oral cancer: trends, challenges and future outlook

 Corresponding author: Bhanu Pratap Sharma Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0. The evolving landscape of oral cancer: trends, challenges and future outlook Bhanu Pratap Sharma 1 *, Khushboo Jain 2, Ravi Kumar Yadav 3 and Prerna Raj 3 1 Shree Vishwakarma Hospital and Research Centre, Dhara Road Sirathu, DistrictKaushambi U.P, India. 2 Khushal Dental Care Noida, India. 3 VMMC and Safdarjung Hospital, Delhi, India. World Journal of Biology Pharmacy and Health Sciences, 2025, 21(02), 063–070 Publication history: Received on 12 December 2024; revised on 01 February 2025; accepted on 04 February 2025 Article DOI: https://doi.org/10.30574/wjbphs.2025.21.2.0085 Abstract Oral cancer is a significant global health concern, ranking among the most common malignancies worldwide, with particularly high incidence rates in developing countries. Despite substantial progress in diagnostic techniques and treatment options, the mortality rate associated with oral cancer remains persistently high. This is primarily due to delayed diagnosis, limited public awareness, and prevalent lifestyle risk factors such as tobacco and alcohol use, as well as human papillomavirus (HPV) infection. Early-stage oral cancer is often asymptomatic, and many patients present with advanced disease, making successful treatment more challenging. This report examines the current trends in oral cancer, with a focus on the challenges encountered in its management and the advancements being made in the field. It highlights the critical epidemiological factors that contribute to the high burden of the disease, including demographic variations, geographical disparities, and the growing impact of HPVrelated cancers. Additionally, the report delves into the risk factors that predispose individuals to oral cancer, such as tobacco use, alcohol consumption, poor oral hygiene, and chronic infections. One of the central topics discussed is early detection, where advancements in diagnostic techniques such as salivary biomarkers, optical imaging, and molecular screening are explored. These technologies hold the potential to improve early-stage detection rates, enabling timely intervention and better outcomes. Furthermore, the report reviews the latest therapeutic interventions, including surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapies. Minimally invasive surgical techniques, advanced reconstruction methods, and novel drug therapies are transforming the landscape of oral cancer treatment, leading to improved survival rates and better quality of life for patients. The report also outlines future perspectives in oral cancer management, emphasizing prevention strategies through public health initiatives, the need for innovative research into biomarkers and treatment options, and the integration of artificial intelligence (AI) in diagnostics and personalized care. Finally, the importance of global collaboration in tackling the challenges of oral cancer is underscored, with recommendations for increasing awareness, improving access to care, and fostering research partnerships. In conclusion, while the burden of oral cancer remains high, ongoing advancements in early detection, treatment modalities, and research offer hope for improved patient outcomes. A concerted effort in prevention, early intervention, and personalized care, coupled with technological innovations and global collaboration, can significantly reduce the global impact of oral cancer, ultimately improving survival rates and quality of life for affected individuals. Keywords: Oral cancer; Risk factors; Early detection; Therapeutic advancements; Public health; Future perspectives World Journal of Biology Pharmacy and Health Sciences, 2025, 21(02), 063–070 64 1. Introduction Oral cancer refers to a group of malignancies that develop in the oral cavity and oropharynx, which includes the lips, tongue, gums, inner lining of the cheeks, floor of the mouth, hard and soft palates, and the throat. It ranks among the top ten most common cancers worldwide and poses a significant public health challenge, particularly in lowand middleincome countries (LMICs), where the burden of the disease is on the rise. According to the World Health Organization (WHO), oral cancer accounts for a substantial proportion of cancer-related deaths globally, with over 350,000 new cases and approximately 177,000 deaths reported annually.1 The etiology of oral cancer is multifactorial, with tobacco use being the leading cause. Smoking cigarettes, cigars, or pipes, as well as using smokeless tobacco products such as chewing tobacco and snuff, significantly increases the risk of developing oral cancer. Alcohol consumption further exacerbates this risk, with studies showing a synergistic effect when combined with tobacco use. In recent years, human papillomavirus (HPV), particularly HPV-16, has emerged as a key risk factor for oropharyngeal cancers, highlighting the importance of viral infections in the disease's pathogenesis. Additionally, poor oral hygiene, chronic irritation from ill-fitting dentures, and a diet deficient in fruits and vegetables are recognized as contributing factors.2 Despite advancements in diagnostic and therapeutic modalities, oral cancer remains a disease with high morbidity and mortality. One of the primary challenges in reducing the burden of oral cancer is the late-stage diagnosis of the disease. Early-stage oral cancer has a favorable prognosis with a five-year survival rate exceeding 80%, whereas late-stage diagnosis significantly reduces survival rates to less than 50%. Unfortunately, a large proportion of cases are detected at advanced stages, primarily due to inadequate screening programs, lack of awareness among the general population, and limited access to healthcare services in resource-constrained settings.3 Geographically, the incidence of oral cancer is particularly high in South and Southeast Asia, including countries such as India, Sri Lanka, Pakistan, and Bangladesh. Cultural practices, such as the use of betel quid, are prevalent in these regions and have been strongly associated with an increased risk of oral cancer. Furthermore, socioeconomic disparities play a crucial role, as individuals from lower socioeconomic backgrounds are more likely to engage in high-risk behaviors and have limited access to early detection and treatment services.4 Early detection and intervention are key strategies in reducing the mortality and morbidity associated with oral cancer. Public health initiatives focusing on increasing awareness about risk factors, promoting regular dental check-ups, and implementing community-based screening programs can significantly improve early diagnosis rates. Additionally, the introduction of HPV vaccination programs can help reduce the incidence of HPV-related oropharyngeal cancers.5 2. Current Trends in Oral Cancer 2.1. Epidemiology Oral cancer is a significant public health concern, accounting for approximately 2% of all cancer cases worldwide. However, the distribution of cases is highly variable across different regions, influenced by lifestyle factors and cultural practices. In South Asia, countries such as India, Bangladesh, Pakistan, and Sri Lanka report some of the highest incidences of oral cancer globally. This is largely attributed to the widespread use of tobacco, betel quid (areca nut wrapped in a betel leaf), and smokeless tobacco products. These traditional practices are deeply ingrained in the culture of these regions, contributing to the high prevalence of oral cancer.6 Conversely, in high-income countries, the incidence of oral cancer has remained relatively stable. However, there has been a notable rise in HPV-related oropharyngeal cancers, particularly among younger, non-smoking populations. This trend is attributed to changes in sexual behaviors and increased exposure to high-risk HPV strains, particularly HPV16. The growing recognition of HPV as a significant etiological factor has shifted the focus of oral cancer prevention strategies in these regions to include HPV vaccination programs.7 Gender disparities are also evident in the epidemiology of oral cancer, with males being more commonly affected than females. This is primarily due to higher rates of tobacco and alcohol use among men. However, the gender gap is narrowing in some regions due to changing social behaviors and increased tobacco use among women.8 World Journal of Biology Pharmacy and Health Sciences, 2025, 21(02), 063–070 65 2.2. Risk Factors The development of oral cancer is strongly associated with several well-established risk factors: • Tobacco Use: Tobacco consumption, in both smoking and smokeless forms, is the most significant risk factor for oral cancer. Smoking cigarettes, cigars, or pipes introduces carcinogens directly to the oral mucosa, increasing the risk of cellular mutations. Smokeless tobacco products, such as chewing tobacco and snuff, are particularly prevalent in South Asia and are strongly associated with oral cancers. • Alcohol Consumption: Alcohol acts as a co-carcinogen, enhancing the carcinogenic effects of tobacco. Heavy alcohol consumption alone can increase the risk of oral cancer, but the combination of alcohol and tobacco use exponentially raises the risk. • HPV Infection: Human papillomavirus (HPV), especially HPV-16, has emerged as a significant risk factor for oropharyngeal cancers. HPV-related oral cancers are often diagnosed in younger individuals and have distinct clinical and pathological features compared to tobacco-related cancers. HPV-positive tumors tend to have a better prognosis and response to treatment. • Poor Oral Hygiene and Chronic Irritation: Poor oral hygiene can lead to chronic inflammation, which predisposes individuals to malignant transformations. Chronic irritation from ill-fitting dentures, sharp teeth, or dental restorations can also contribute to the development of oral lesions that may become cancerous. • Diet and Nutrition: A diet deficient in fruits and vegetables, which are rich in antioxidants and essential nutrients, has been linked to an increased risk of oral cancer. Nutritional deficiencies, particularly of vitamins A, C, and E, can compromise the body's ability to repair DNA damage caused by carcinogens. • Genetic and Familial Factors: Genetic predisposition plays a role in some cases of oral cancer. Individuals with a family history of cancer may have an increased risk due to inherited genetic mutations that affect cell growth and repair mechanisms.9 2.3. Clinical Presentation The clinical presentation of oral cancer can vary widely depending on the location and stage of the disease. Common early signs include: • Non-Healing Ulcer: One of the most common presentations of oral cancer is a persistent ulcer in the mouth that does not heal within two weeks. These ulcers are often painless initially but may become painful as the disease progresses. • Lump or Thickening: Patients may notice a lump or thickening in the cheek, tongue, or floor of the mouth. These lumps can be firm and immovable, indicating invasive growth. • White or Red Patches: Leukoplakia (white patches) and erythroplakia (red patches) are common precancerous lesions that can develop into malignancies. Erythroplakia, in particular, has a higher risk of malignant transformation. • Difficulty Swallowing (Dysphagia): Tumors in the oropharynx or base of the tongue can cause difficulty swallowing. Patients may also experience a sensation of something being stuck in the throat. • Speech Changes: Tumors affecting the tongue, lips, or palate can cause changes in speech, including slurring or difficulty articulating words. • Unexplained Weight Loss: As with many cancers, unexplained weight loss can be a sign of advanced disease. This may be due to reduced oral intake caused by pain or difficulty eating. • Persistent Sore Throat or Ear Pain: In cases of oropharyngeal cancer, patients may experience a persistent sore throat or referred pain to the ear.10 Early-stage oral cancer is often asymptomatic, which contributes to delayed diagnosis. By the time symptoms become noticeable, the disease may have already advanced. This highlights the importance of regular dental check-ups and early screening programs to detect oral cancer at a treatable stage. 3. Challenges in Oral Cancer Management 3.1. Late Diagnosis Oral cancer is often diagnosed at a later stage, when the cancer has spread and treatment options are more limited. The late-stage presentation is primarily due to: World Journal of Biology Pharmacy and Health Sciences, 2025, 21(02), 063–070 66 • Asymptomatic Early Stages: In many cases, early oral cancers may not show symptoms, making detection difficult. • Lack of Awareness: Most patients are unaware of the signs of oral cancer, such as persistent sores, pain, or changes in the mouth. The absence of routine screenings also contributes to delayed diagnoses. • Limited Screening Programs: Screening programs for oral cancer are not widely implemented, especially in lowand middle-income countries, where the majority of oral cancer cases occur.11 3.2. Access to Care • Geographical Barriers: In rural or underdeveloped regions, there is often limited access to specialized cancer centers and professionals. • Cost of Treatment: The cost of cancer treatment—such as surgery, chemotherapy, and radiation therapy—can be prohibitive, especially in areas with limited healthcare resources. • Infrastructure Gaps: Some regions lack the necessary infrastructure, including diagnostic imaging and laboratories, to detect and treat oral cancer effectively. 3.3. Treatment-Related Complications • Functional Issues: Surgery, especially when it involves resection of the oral cavity, can result in significant longterm effects, such as: o Speech and Swallowing Difficulties: Many patients struggle with communication and eating after surgery, affecting their quality of life. o Disfigurement: Extensive resections of the mouth, jaw, or face may lead to visible disfigurement, which can have profound psychological effects on patients. • Side Effects of Chemotherapy and Radiation: These treatments often cause severe side effects like nausea, fatigue, mucositis, and immunosuppression, further compromising the patient’s quality of life. • Psychological Distress: The combination of functional impairments, disfigurement, and the burden of ongoing treatment often leads to anxiety, depression, and a sense of helplessness among patients.12 3.4. Public Awareness Lack of awareness about oral cancer’s risk factors (e.g., tobacco use, alcohol consumption, HPV infection) and early symptoms contributes to late-stage presentation. Effective public health campaigns are essential to: • Promote Early Detection: Encouraging regular oral exams and educating the public on signs and symptoms of oral cancer can lead to earlier diagnoses. • Lifestyle Modifications: Public campaigns can help reduce modifiable risk factors, such as smoking and heavy drinking, and promote HPV vaccination as a preventive measure.13 4. Advancements in Diagnosis and Treatment 4.1. Early Detection Strategies Several promising advancements are making it easier to detect oral cancer in its early stages: • Salivary Biomarkers: The analysis of salivary markers can identify molecular changes associated with oral cancer, offering a non-invasive and cost-effective screening tool. • Optical Imaging: Technologies like fluorescence and confocal microscopy allow for the visualization of abnormal tissue in the oral cavity, enabling earlier detection of precancerous lesions. • Molecular Screening: Techniques such as genetic and epigenetic screening can detect changes at the molecular level, even before clinical signs of cancer appear.14 4.2. Surgical Techniques • Minimally Invasive Surgery: Robotic and laser-assisted surgeries allow for more precise tumor resections with smaller incisions. This reduces post-operative complications and recovery time. • Reconstructive Surgery: Advances in microvascular free flap reconstruction have greatly improved the aesthetic and functional outcomes for patients undergoing extensive oral resections. This allows for better preservation of speech, swallowing, and appearance.15 World Journal of Biology Pharmacy and Health Sciences, 2025, 21(02), 063–070 67 4.3. Immunotherapy • Checkpoint Inhibitors: Immunotherapies like pembrolizumab, which target immune checkpoints, have shown promising results in treating advanced oral cancers. These treatments enhance the body’s immune system to recognize and fight cancer cells. • Cancer Vaccines: Researchers are exploring vaccines that target specific proteins involved in oral cancer, offering potential for preventive or adjuvant therapies. 4.4. Targeted Therapy • Personalized Treatment: Targeted therapies are designed to attack specific molecules involved in cancer progression. For oral cancer, this could mean targeting specific genetic mutations or proteins that drive tumor growth. • Reduced Side Effects: Compared to traditional chemotherapy, targeted therapies are often less toxic, offering the potential for more effective and less harmful treatments. • Combination Therapies: Combining targeted therapies with traditional treatments such as chemotherapy or radiation may improve patient outcomes, especially in advanced stages.16 5. Future Perspectives in Oral Cancer Management 5.1. Prevention Strategies Effective prevention strategies are essential to reducing the incidence of oral cancer. Future efforts in prevention should focus on the following: • Tobacco and Alcohol Use Reduction: Since tobacco and alcohol are major risk factors for oral cancer, public health initiatives should continue to target the reduction of their consumption. This includes stricter tobacco control policies, higher taxes on tobacco and alcohol, and anti-smoking campaigns that focus on the risks of oral cancers. • Human Papillomavirus (HPV) Vaccination: HPV has been identified as a significant cause of oral cancers, particularly those affecting the oropharynx. Expanding HPV vaccination programs worldwide can prevent a significant portion of oral cancers. Efforts should focus on increasing vaccination rates in both young girls and boys, as well as promoting awareness of the HPV-oral cancer link. • Oral Hygiene Education: Improving oral hygiene practices and increasing awareness about the importance of regular dental check-ups can help reduce the incidence of oral cancer. Research into the links between chronic gum disease and oral cancer should also inform preventive strategies. • Screening Programs: Implementing widespread oral cancer screening programs, especially in high-risk populations such as tobacco users and those with a history of HPV infection, is crucial for early detection. These programs should be integrated into routine healthcare systems, particularly in resource-limited settings.17,18,19 5.2. Research Directions Continued research into oral cancer is critical for the development of more effective preventive, diagnostic, and therapeutic strategies. Key research directions include: • Novel Biomarkers: Identifying biomarkers that can detect oral cancer at its earliest stages is paramount. These biomarkers could be found in saliva, blood, or tissue, offering non-invasive or minimally invasive diagnostic options that allow for earlier detection and better prognosis. • Genetic and Molecular Mechanisms: Understanding the genetic mutations and molecular signaling pathways that drive the progression of oral cancer is critical for developing targeted therapies. Future research should focus on the molecular drivers of both primary and recurrent oral cancers, as well as the role of the tumor microenvironment in metastasis. • Targeted Therapies and Immunotherapy: The development of new, personalized treatments is essential. Research into targeted therapies that focus on specific molecular markers involved in oral cancer progression can lead to more effective and less toxic treatments. Additionally, the continued exploration of immunotherapy offers potential for improving survival in advanced cases. • Quality of Life for Survivors: Oral cancer treatment often results in long-term functional and psychological issues. Research should address ways to improve the quality of life for survivors, including rehabilitation World Journal of Biology Pharmacy and Health Sciences, 2025, 21(02), 063–070 68 strategies for speech and swallowing, as well as psychological support to help patients cope with disfigurement and the emotional toll of cancer treatment. 5.3. Technological Innovations Emerging technologies are poised to revolutionize the diagnosis and treatment of oral cancer: • Artificial Intelligence (AI) in Diagnostic Imaging: AI can enhance the accuracy and speed of oral cancer diagnosis. AI-powered imaging systems, such as those that analyze X-rays, MRIs, or endoscopic images, can detect early-stage lesions with high sensitivity. By analyzing large datasets, AI can also predict cancer progression, suggest treatment regimens, and personalize care plans. • AI in Patient Monitoring: AI can help monitor patient outcomes and side effects during treatment. By tracking biomarkers, patient-reported symptoms, and clinical data, AI systems can provide real-time feedback to clinicians, enabling timely interventions and adjustments to treatment plans. • 3D Printing and Personalized Medicine: The use of 3D printing in oral cancer surgery allows for the creation of patient-specific surgical guides and prosthetics, reducing the risk of complications and improving postsurgical outcomes. Furthermore, personalized medicine approaches, informed by genomics and AI, can guide treatment decisions, improving efficacy and reducing unnecessary side effects. 5.4. Global Collaboration Tackling oral cancer requires a united, global approach to address the disparities in healthcare access, resources, and research. Global collaboration can be fostered through: • International Partnerships: Governments, healthcare organizations, and research institutions worldwide should collaborate on shared goals for oral cancer prevention, research, and treatment. This can include joint research initiatives, shared clinical trials, and pooled data to increase understanding of the disease. • Resource Sharing and Capacity Building: Many low-resource countries struggle with access to care and lack specialized knowledge. Collaborative efforts can help build local healthcare infrastructure, train healthcare professionals, and ensure that effective treatment protocols are accessible to all, regardless of income or location. • Policy Advocacy: International advocacy for oral cancer prevention and early detection, especially through lobbying for stronger tobacco control and increased funding for cancer research, is essential in reducing the global burden of the disease.20,21,22,23 6. Conclusion Oral cancer remains a significant global health challenge, particularly in lowand middle-income countries where access to care is limited. While advancements in diagnosis and treatment have improved patient outcomes, challenges such as late-stage diagnosis, lack of public awareness, and inadequate healthcare infrastructure persist. Future efforts must focus on prevention through lifestyle changes, HPV vaccination, and public health campaigns. Research into novel biomarkers, personalized therapies, and improving the quality of life for survivors is vital to advancing treatment. Technological innovations, particularly in AI, offer promising tools for early detection and personalized care. Finally, global collaboration is essential for tackling oral cancer in a comprehensive and effective manner. By addressing these challenges and leveraging the advances in medical research, healthcare delivery, and technology, the global burden of oral cancer can be significantly reduced. This will lead to better survival rates, reduced morbidity, and improved quality of life for patients worldwide. Compliance with ethical standards Disclosure of conflict of interest No conflict of interest to be disclosed. World Journal of Biology Pharmacy and Health Sciences, 2025, 21(02), 063–070 69 References [1] Coletta RD, Yeudall WA, Salo T. Current trends on prevalence, risk factors and prevention of oral cancer. Front Oral Health. 2024 Nov 13; 5:1505833. doi: 10.3389/froh.2024.1505833. PMID: 39606098; PMCID: PMC11599248. [2] Miranda-Filho A, Bray F. Global patterns and trends in cancers of the lip, tongue, and mouth. Oral Oncol. (2020) 102:104551. DOI: 10.1016/j.oraloncology.2019.104551 [3] Eloranta R, Vilén S-T, Keinänen A, et al. Oral squamous cell carcinoma: effect of tobacco and alcohol on cancer location. Tob Induc Dis. (2024) 22. DOI: 10.18332/tid/189303 [4] Coletta RD, Yeudall WA, Salo T. Grand challenges in oral cancers. Front Oral Health. (2020) 1:3. DOI: 10.3389/froh.2020.00003 [5] Tarasenko Y, Ciobanu A, Fayokun R, et al. Electronic cigarette use among adolescents in 17 European study sites: findings from the global youth tobacco survey. Eur J Public Health. (2022) 32(1):126–32. DOI: 10.1093/eurpub/ckab180 [6] Kassem NOF, Strongin RM, Stroup AM, et al. A review of the toxicity of ingredients in e-cigarettes, including those having the FDA’s “generally recognized as safe (GRAS)” status. Nicotine Tob Res. (2024) 26(11):1445–54. DOI: 10.1093/ntr/ntae123 [7] Klawinski D, Hanna I, Breslin NK, et al. Vaping the venom: oral cavity cancer in a young adult with extensive electronic cigarette use. Pediatrics. (2021) 147(5):e2020022301. DOI: 10.1542/peds.2020-022301 [8] Baniulyte G, Ali K. Do e-cigarettes have a part to play in peri-implant diseases? Evid Based Dent. (2023) 24(1):7– 8. DOI: 10.1038/s41432-023-00864-w [9] Guo X, Hou L, Peng X, Tang F. The prevalence of xerostomia among e-cigarette or combustible tobacco users: a systematic review and meta-analysis. Tob Induc Dis. (2023) 21:22. DOI: 10.18332/tid/156676 [10] Maan M, Abuzayeda M, Kaklamanos EG, et al. Molecular insights into the role of electronic cigarettes in oral carcinogenesis. Crit Rev Toxicol. (2023) 53(1):1–14. DOI: 10.1080/10408444.2023.2190764 [11] Iacob AM, Escobedo Martínez MF, Barbeito Castro E, et al. Effects of vape use on oral health: a review of the literature. Medicina (Kaunas). (2024) 60(3):365. DOI: 10.3390/medicina60030365 [12] Constantin M, Chifiriuc MC, Mihaescu G, et al. Implications of oral dysbiosis and HPV infection in head and neck cancer: from molecular mechanisms to therapy. Front Oncol. (2023) 13:1273516. DOI: 10.3389/fonc.2023.1273516 [13] Simoens C, Gorbaslieva I, Gheit T, et al. HPV DNA genotyping, HPV E6*I mRNA detection, and p16(INK4a)/ki-67 staining in Belgian head and neck cancer patient specimens. Cancer Epidemiol. (2021) 72:101925. DOI: 10.1016/j.canep.2021.101925 [14] Sichero L, Gonçalves MG, Bettoni F, et al. Detection of serum biomarkers of HPV-16-driven oropharynx and oral cavity cancer in Brazil. Oral Oncol. (2024) 149:106676. DOI: 10.1016/j.oraloncology.2023.106676 [15] Søland TM, Bjerkli IH, Georgsen JB, et al. High-risk human papilloma virus was not detected in a Norwegian cohort of oral squamous cell carcinoma of the mobile tongue. Clin Exp Dent Res. (2021) 7(1):70–7. DOI: 10.1002/cre2.342 [16] Pinkiewicz M, Dorobisz K, Zatoński T. Human papillomavirus-associated head and neck cancers: where are we now? Cancer Manag Res. (2022) 14:3313–24. DOI: 10.2147/CMAR.S379173 [17] Bouvard V, Nethan ST, Singh D, et al. IARC Perspective on oral cancer prevention. N Engl J Med. (2022) 387(21):1999–2005. DOI: 10.1056/NEJMsr2210097 [18] Aden D, Zaheer S, Khan S, et al. Navigating the landscape of HPV-associated cancers: from epidemiology to prevention. Pathol Res Pract. (2024) 263:155574. DOI: 10.1016/j.prp.2024.155574 [19] Fu E, Erdemir O, Pathan K, et al. A review of human papillomavirus vaccination and associated ethical concerns. Infect Chemother. (2024). DOI: 10.3947/ic.2024.0070 [20] Ribeiro MFA, Oliveira MCM, Leite AC, et al. Assessment of screening programs as a strategy for early detection of oral cancer: a systematic review. Oral Oncol. (2022) 130:105936. DOI: 10.1016/j.oraloncology.2022.105936 World Journal of Biology Pharmacy and Health Sciences, 2025, 21(02), 063–070 70 [21] Thankappan K, Subramanian S, Balasubramanian D, et al. Cost-effectiveness of oral cancer screening approaches by visual examination: a systematic review. Head Neck. (2021) 43(11):3646–61. DOI: 10.1002/hed.26816. [22] I. Ganly, Y. Hao, M. Rosenthal, H. Wang, J. Migliacci, B. Huang, et al. Oral microbiome in nonsmoker patients with oral cavity squamous cell carcinoma, defined by metagenomic shotgun sequencingCancers, 14 (2022), 10.3390/cancers14246096. [23] I. Ganly, L. Yang, R.A. Giese, Y. Hao, C.W. Nossa, L.G.T. Morris, et al.Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus